You are worth tens of billions before you come to the system?

In early August, Lin Zitai returned to Shanghai to announce the release date and price of K-drug.

Each injection costs RMB 1,000, join the medical insurance system, and donate 10,000 injections to various countries for free in the name of caring for cancer patients.

When the news came out, Merck responded quickly, saying that Prince Group's K drug had only gone through two phases of clinical trials, posed huge safety risks, and treated the lives of cancer patients as child's play.

It is hoped that all countries will strengthen the review of imported drugs and resolutely prevent irregular drugs from entering the markets of various countries.

At the same time, the Prince Group was sued for drug patent infringement...

Liu Xiaojun also stood up and responded that they had not infringed the patent, and the product had successfully passed the review of the State Food and Drug Administration after many clinical trials. He then sued Merck to the International Court of Justice for slander and frame-up.

After both sides sing, I will appear...

Just like elementary school students fighting each other, they all say something wrong about the other party and launch billions of dollars in compensation lawsuits against the other party.

But before the lawsuit even started, the two sides were arguing over the country of origin of the case.

Merck hopes to be tried in a New York court, while Prince Group hopes to be tried in a Shanghai court.

In commercial judicial cases involving enterprises between major countries, the local courts will be unconditionally biased...

After all, paying so much tax every year is not for nothing.

October 8th, Thursday.

Lin Zitai took a special plane to Xiangjiang and met with Samsung Mitsui and the person in charge of Daiichi Life.

Four multinational groups jointly established an investment company registered in the Cayman Islands with a registered capital of US$1000 billion.

Novartis holds 40%, Samsung holds 25%, and Mitsui and Daiichi Life each hold 17.5%.

Saito Victory also took the opportunity to ask about the next plan. The big price reduction of K drug should have been the most important trump card, but because Lin Zitai announced the financing target too early, Merck was ready.

Now that the price of K drug is announced, Merck's stock price has fallen by less than 10%, and it still has a market value of US$4080 billion.

If they take action at this time, even if they have hundreds of billions of dollars in capital, it will be difficult to take advantage.

The prerequisite for the merger is to hold 33.4% of the shares, which means that Merck's stock price must fall below 3000 billion before they have the possibility of a successful merger.

More than 4000 billion, entering the market now is to deliver food.

Lin Zitai pondered for a moment and said: "Ganlin hair growth hormone has passed the review in Mexico and Canada. We plan to focus on promoting hair growth products to stabilize Novartis' stock price first."

Novartis cannot handle the Food and Drug Administration of Laos and the United States, but it is still able to handle neighboring countries such as Laos and Mexico.

At the end of July, on the day Lin Zitai left New York, the approval documents from Mexico and Canada had been issued.

They plan to price each set at US$268, which is equivalent to nearly 1850 yuan in soft sister coins.

Merck is no better than Novartis, so this merger and acquisition plan cannot be rushed and can only be done slowly.

"To fight against the outside world, we must first secure the inside. The next step is to wait until Novartis's market value returns to US$100 billion before proceeding."

Lin Zitai appropriately put it aside. Cooperating with Japanese and Korean companies is no less than seeking skin from a tiger.

They can betray their beautiful father, and naturally they can betray him, so they can't let them know too much.

But one hundred billion US dollars is not a small amount after all, it is equivalent to the annual GDP of small and medium-sized developing countries.

"You can each arrange a financial officer to supervise the expenditure of the company's funds."

Lin Zitai paused and then said: "But I also put the ugly words first. Supervision can but cannot interfere."

"Of course we will not be so unreasonable. Starting from September, we will hold a meeting between the 1st and 5th of each month."

"We will truthfully inform you of the US$1000 billion in capital expenditures and the investment projects."

"What do you think?"

Several people looked at each other and had no objections, and said that they would try their best to assist the distribution of K drugs in Japan and South Korea.

The next day, news spread like wildfire that Novartis and Samsung Mitsui Dai-ichi Life, four companies spending hundreds of billions of dollars to establish investment companies.

That night, Novartis's stock price bucked the trend and rose, regaining lost ground of US$500 billion... US$550 billion, and breaking through the five-day line for the first time in many days.

Correspondingly, Merck's share price fell 5.5%, falling below the US$4000 billion mark.

Only then did they realize that Lin Zitai did not give in and only withdrew his punches to do better next time.

At the same time, Novartis announced that it would spend $200 million to launch a hair growth plan.

Invite European and American bald male stars, such as Van Dier, Statham, or Beckham and other well-known stars.

For a period of two months, they were allowed to participate in the hair growth hormone project, which was exactly the same as the original promotion of the Prince Group. Parks studied the product promotion process in China and found that inviting male stars to participate in hair growth projects played a key role.

For two months without interruption, I posted a photo on social platforms, allowing fans to see with their own eyes that dead trees are turning into spring and old trees are taking root.

As of the end of July, the total sales of hair growth kits in mainland China reached 764 million copies, with sales reaching 74.68 billion yuan.

This achievement has been achieved in just over four months since it was launched, which is closely related to the original promotion strategy.

So they followed the same pattern, and the routines were not afraid of aging. The most important thing was that they were easy to use. After all, Lin Zitai was one of their own.

October 8th, Sunday.

After more than a month of running around, Lin Zitai returned to the Prince's Building and came to the laboratory to start developing new drugs.

The nine-valent vaccine is still undergoing its third phase of clinical trials and will not be approved for marketing until at least January or February next year.

Just relying on a K drug is not enough to defeat the huge Merck empire, and more powerful drugs are needed.

Musk's brain computer is a good idea, but unfortunately it has no direct competition with Merck.

Therefore, the brain-computer project can only be postponed a little bit, and the top priority should still be to complete the acquisition of Merck.

This is Lin Zitai’s commitment to Novartis.

After several days of investigation, he finally focused on another drug, tilpotide, a GIP dual-target receptor agonist.

It is suitable for chronic weight management of obese or overweight patients. It is effective in reducing blood sugar and weight, and is a specific medicine for type 2 diabetes.

The nine-valent vaccine and K drug accounted for 55% of Merck's annual revenue, while tilpotide accounted for about 14%.

Since its launch in March 18, it has immediately entered the top 3 best-selling drugs in the world, with annual revenue of approximately US$50 billion.

When dealing with Novartis, it took Lin Zitai nine months to bring him down from the altar, and finally he was able to successfully take over.

This time, the acquisition of the stronger Merck will only be cyclical, but he is patient and can afford to wait...

In the blink of an eye, the end of August has arrived. In recent days, the entire European and American continent has been flooded with Ganlin Hair Growth Toxin.

People’s eyes are sharp, and they are not blind. They have already used various social platforms.

Watching those bald celebrities, fine hair gradually grows on their bare heads.

On the other hand, they can only cry every day looking at the pillows covered with hair loss and the bathroom drains clogged with hair.

That feeling can be described as being on pins and needles, like thorns on the back, like a lump in the throat...

Some people with channels have already used overseas purchasing agents to buy in advance from China or Asian markets.

Those without channels had no choice but to unite and demonstrate downstairs at the Novartis headquarters in New York.

Why can mainland China be released in March and Asian countries can be released collectively in July?

On the other hand, the people in Europe and the United States still have to endure the tricks of Novartis Group?

If you don’t have the ability to sell it, give up the agency rights of Ganlin Hair Growth Serum, and don’t occupy the manhole.

They don't bother to care so much, and they don't want to know the inside story.

For them, the most painful thing is not that they are becoming bald day by day, but that they are becoming bald while others can grow.

Lin Zitai learned the news and hurriedly ordered Parks not to respond for the time being. At the same time, he would approve funds to increase the number of parades and make the matter a big deal.

Lin Zitai said with a smile: "It would be a despicable waste not to take advantage of such good public opinion."

As of last night, Novartis Group's closing market value was only US$586.5 billion. As long as this wave of public opinion is taken advantage of, the market value may reach hundreds of billions of dollars.

Can we also criticize the Wall Street rating agencies for not giving them only C- or D-level junk stocks?

So what if the stock price rose sharply against the trend?

It would be a major blow to their credit system.

It can even force the US Food and Drug Administration to pass the review of hair growth hormone and K-drug.

"The power of civilian products lies in the huge audience, and the United States is a very free country on the surface."

Lin Zitai also had to lament that God-given opportunities would be struck by lightning if not cherished.

This kind of public opinion is absolutely impossible to happen in China. After all, organizing a parade is difficult.

But the national conditions of the United States are different. People can gather in the streets to demonstrate over trivial matters.

It is even more common to be kidnapped by public opinion, because those in power need the votes of the people. (End of chapter)